NCT05153629

Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.

Conditions

• Kidney Stone
• Ureteral Calculi
• Nephrolithiasis

Interventions

Type	Name	Description
DEVICE	TENS	TENS device used four times a day for 60 minutes each time

Timeline

• Start date: 2021-01-10
• Primary completion: 2023-10-01
• Completion: 2023-10-01
• First posted: 2021-12-10
• Last updated: 2024-10-22
• Results posted: 2024-10-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study